Clinical Trials Logo
  1. Home
  2. Ocular Physiology
  3. NCT00706927

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Physiology Clinical Trial

Official title:
A Double-masked Randomized Cross-over Study Comparing of the Effect of Xalacom® (Latanoprost/Timolol)and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Clinical Trial Summary

Glaucoma is one of the most common causes of blindness in the industrialized nations. For a long time glaucoma has been defined as a disease in which high intraocular pressure (IOP) leads to irreversible optic disc damage and subsequent visual field loss. However, recent investigations show that IOP is not the only factor that is involved in the glaucomatous process leading to retinal ganglion cell death. The role of vascular factors in the pathogenesis of glaucoma has recently received much attention based on animal experiments and epidemiological studies. The main focus of glaucoma is still directed towards a decrease in IOP. There is, however, also considerable interest whether antiglaucoma drugs influence ocular perfusion. Although measurement of ocular blood flow is still difficult, a number of innovative techniques have been realized which cover different aspects of ocular perfusion. In the present study Xalacom® (latanoprost/timolol) and the fixed combination of Combigan® (brimonidine/timolol) will be compared with respect to their IOP lowering efficacy as well as their ocular hemodynamic effects.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00706927
Study type Interventional
Source Medical University of Vienna
Contact
Status Completed
Phase N/A
Start date January 2006
Completion date September 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00431392 - Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions Phase 2
Completed NCT06161012 - Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear N/A
Terminated NCT00708357 - Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head? Phase 0
Completed NCT05291936 - Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear N/A
Withdrawn NCT00712777 - Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism N/A
Completed NCT00709423 - Effects of Moxaverine and Placebo on Ocular Blood Flow Phase 2
Completed NCT00708929 - Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? N/A
Completed NCT00712400 - Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects N/A
Completed NCT01663688 - Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye N/A
Completed NCT05427539 - Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process N/A
Completed NCT05713552 - Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock N/A
Withdrawn NCT00406731 - Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure Phase 2
Completed NCT00275730 - Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers N/A
Completed NCT00712764 - Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure. N/A
Withdrawn NCT05530889 - Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies N/A
Completed NCT00312416 - Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise Phase 4
Completed NCT00712907 - Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow N/A
Completed NCT00431730 - Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers? N/A
Withdrawn NCT00991900 - Short Term and Day to Day Reproducibility of Reflectometric Measurement of Retinal Oxygen Saturation in Healthy Subjects
Completed NCT00280501 - Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions N/A